RNA Therapeutics Part B

Dr. Chu is currently the Director of the Center for Biomedicine and Community Health and the Dean of the Faculty of Applied Sciences, International School, Vietnam National University (VNU), Hanoi, Vietnam. He is also a visiting Professor at the Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan. He achieved a Doctor of Veterinary Medicine degree from Vietnam in 2006, a Master of Biological Science from in South Korea in 2011. From 2011 to 2015, he participated in an EU-funded program in. Poland for the Ph.D. program in diet-induced obesity, genetic effects, and epigenetic regulations of lipid metabolism and obesity, and got a PhD in medicine (medical Biology). Dr. Chu continued his journey as a postdoc and researcher in molecumar biomoedicine under a Marie Curie Postdoctoral Research Fellowship at the Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo (Norway) from 2015 to 2018. Up to now, he has over 190 WoS/Scopus publications in biomedicne and community health with more than 21000 citations (Scopus, updated by 5/2023). He has also reviewed over 40 qualified scientific journals with more than 300 manuscripts and handed over 250 manuscripts as an editor for several WoS/Scopus journals such as Bioengineered and PLOS ONE. In 2022, the Stanford List recognized him as the Top 2% Scientists in the World. Dr. Thai received his DVM in 2006 in Vietnam; a PhD in biomedicine in 2014 at the Faculty of Medicine, Chung-Ang University, Korea. He served as Postdoctoral Researcher and Research Professor at the Faculty of Medicine, Chung-Ang University for three consecutive years before joining the Faculty of Biotechnology, Nguyen Tat Thanh University, then Faculty of Biotechnology, Chemistry, and Environmental Engineering, Phenikaa University; and now Faculty of Applied Sciences, International School, VNU. His interest fields are included microbial epidemiology, microbial evolution, microbial immunology, gene expression, vaccine, and sub-unit vaccine. Dr. Thai has extensive working experiences with various types of microbes, including the human microbes (Rotavirus, Norovirus, Parechovirus), the animal microbes (Influenza Virus, Foot-and-Mouth Disease Virus, Infectious Bronchitis Virus), and plant microbes (Sri-Lanka Cassava Mosaic Virus, Enterobacter cloacae). His most recent research is the infection of Human Papilloma Virus (HPV) in Vietnam. This research focuses on HPV detection, HPV genotype identification, HPV vaccine evaluation. The results will provide evidence for that the HPVs remain as a reservoir of causing human papillomavirus carcinogen as well as suggesting for the development of appropriate HPV detection kit and vaccine in Vietnam.

Preface
Dinh -Toi Chu and Van Thai Than
1. RNA therapeutics for cardiovascular disorders
Negin Parsamanesh
2. RNA therapeutics for non- alcoholic fatty liver diseases
Ali Mahmoudi
3. RNA therapeutics for kidney injury
Pouya Goleij
4. RNA therapeutics for beta-thalassemia
Hong Quan Duong
5. RNA therapeutics for infectious diseases
Van Thai Than
6. RNA therapeutics for reproductive diseases
Mehmet Firat Mutlu
7. Potential of RNA and transcriptomic data to drive drug repurposing for various diseases
Lalu Muhammad Irham
8. RNA therapeutics for glioma/glioblastoma
Amir R Afshari
9. RNA therapeutics for regenerative medicine
Dinh -Toi Chu
10. Advances in the liposome-based delivery systems for RNA therapeutics in cancer
Amir R Afshari
11. Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics in cancer
Prashant Kesharwani
12. Advances in RNA therapeutics for modulation of ´undruggable´ targets
Emily Martinsen and Marie Rogne
13. Biosafety and regulatory issues of RNA therapeutics
Dinh -Toi Chu